COVID-19 – un premier donneur de plasma de convalescents
April 29, 2020 16:30 ET
|
Société canadienne du sang
VANCOUVER, Colombie-Britannique, 29 avr. 2020 (GLOBE NEWSWIRE) -- La Société canadienne du sang est fière de participer à CONCOR, un essai clinique national visant à déterminer si le plasma de...
First Patient Dosed in Avdoralimab Phase II Clinical Trial in COVID-19 Patients With Severe Pneumonia
April 28, 2020 01:00 ET
|
INNATE PHARMA
MARSEILLE, France, April 28, 2020 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the first patient was...
First patient dosed in avdoralimab Phase II clinical trial in COVID-19 patients with severe pneumonia
April 28, 2020 01:00 ET
|
INNATE PHARMA
Initial translational analysis, EXPLORE, showed overexpression of C5a/C5aR pathway in patients with severe COVID-19 Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate”...
Premier patient traité dans l'essai de Phase II évaluant avdoralimab chez des patients atteints d'une pneumonie sévère due au COVID-19
April 28, 2020 01:00 ET
|
INNATE PHARMA
L’étude translationnelle initiale, EXPLORE, a montré une surexpression de la voie C5a/C5aR chez les patients présentant un COVID-19 sévère Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421...
Rafael Pharmaceuticals Receives Approvals to Open Trial Sites in India and Canada for Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
April 23, 2020 09:00 ET
|
Rafael Pharmaceuticals, Inc.
Cranbury, NJ, April 23, 2020 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced that...
Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Antibody SRF388
April 23, 2020 08:00 ET
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Norton Healthcare enrolls first patient in world for COVID-19 drug trial
April 21, 2020 10:04 ET
|
Norton Healthcare
Louisville, KY, April 21, 2020 (GLOBE NEWSWIRE) -- A COVID-19 patient at Norton Healthcare is the first in the world to participate in a randomized Phase 2 clinical study using low-dose selinexor....
Fluidigm Announces Conference Call and Webcast of First Quarter 2020 Financial Results
April 20, 2020 16:06 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., April 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Notable Announces Leadership Team Expansion
April 09, 2020 14:03 ET
|
Notable Labs
SAN FRANCISCO, April 09, 2020 (GLOBE NEWSWIRE) -- Notable, a technology leader redefining cancer treatment through rapid drug development via a clinically validated platform, announced today its...
BIOCARDIA REPORTS 2019 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
April 09, 2020 14:03 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., April 09, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...